Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

11.47
Delayed Data
As of 4:00pm ET
 +0.02 / +0.17%
Today’s Change
2.02
Today|||52-Week Range
12.96
+212.53%
Year-to-Date

Today’s Trading

Previous close11.45
Today’s open11.30
Day’s range11.25 - 11.49
Volume1,852,703
Average volume (3 months)2,505,526
Market cap$1.4B
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-137.10%
Earnings growth (this year)+62.81%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-4.39%
P/E ratioNM
Price/Sales298.60
Price/Book--

Competitors

 Today’s
change
Today’s
% change
QDELQuidel Corp-0.03-0.07%
--Quidel Corp-0.59-1.64%
MYGNMyriad Genetics Inc+0.18+0.54%
ALRPRBAlere Inc+0.63+0.16%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$3.1M
Annual profit (last year)-$153.2M
Net profit margin-4,956.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Vice President
Michael R. Garone
Director, Chief Scientific &
Patent Officer
David M. Goldenberg
Corporate headquarters
Morris Plains, New Jersey

Forecasts